Zepbound — the brand name for tirzepatide — is the most effective GLP-1 medication for weight loss, according to one study.

Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) ...

First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...

In fact, you may have gotten more than a few targeted ads on social media from telehealth platforms selling these cheaper GLP ...

Should you exercise differently if you’re on a GLP-1 weight loss drug such as Ozempic or Wegovy? Here’s what to know about which physical activities best support your health goals.

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

However, while both drugs target the hormone known as GLP-1, tirzepatide also targets ... gastrointestinal side effects. Demand for effective obesity medications extends globally, with rising sales of ...

Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...

The request follows a similar move by Eli Lilly, which has asked for a ban on other parties making copies of its tirzepatide-based therapies Mounjaro for diabetes and Zepbound for obesity ...

The FDA explicitly states that retatrutide, another investigational GLP-1 drug, cannot be legally used in compounding. It is not an ingredient in any FDA-approved drug and has not been established as ...